Search Results - "Fonseca, Leonardo G"

Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice by Rimola, Jordi, Da Fonseca, Leonardo G., Sapena, Víctor, Perelló, Christie, Guerrero, Antonio, Simó, Maria Torner, Pons, Monica, De La Torre-Aláez, Manuel, Márquez, Laura, Calleja, José Luis, Lledó, José Luis, Varela, Maria, Mínguez, Beatriz, Sangro, Bruno, Matilla, Ana, Torres, Ferran, Ayuso, Carmen, Bruix, Jordi, Reig, Maria

“…•Imaging findings at different timepoints for HCC treated with nivolumab vary between patients and within patients.•The possibility of pseudoprogression must…”
Get full text

Return to work after breast cancer diagnosis: An observational prospective study in Brazil by Landeiro, Luciana C. G., Gagliato, Debora M., Fêde, Angelo B., Fraile, Natalia M., Lopez, Rossana M., da Fonseca, Leonardo G., Petry, Vanessa, Testa, Laura, Hoff, Paulo M., Mano, Max S.

“…Background In North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36…”
Get full text

Insights into the success and failure of systemic therapy for hepatocellular carcinoma by Bruix, Jordi, da Fonseca, Leonardo G., Reig, María

“…Systemic treatment for hepatocellular carcinoma (HCC) has been boosted by the incorporation of new agents after many negative phase III trials in the decade…”
Get full text

Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs by Díaz‐González, Álvaro, Sapena, Víctor, Boix, Loreto, Torres, Ferrán, Sanduzzi‐Zamparelli, Marco, Fonseca, Leonardo G., LLarch, Neus, Iserte, Gemma, Guedes, Cassia, Muñoz‐Martínez, Sergio, Darnell, Anna, Belmonte, Ernest, Rimola, Jordi, Forner, Alejandro, Ayuso, Carmen, Bruix, Jordi, Reig, María

“…Background Despite atezolizumab and bevacizumab (A + B) is currently the first‐line treatment for hepatocellular carcinoma (HCC) patients, some patients will…”
Get full text

Brazilian Landscape of Hepatocellular Carcinoma by Fonseca, Leonardo G, Chen, Andre T C, de Oliveira, Irai S, Chagas, Aline L, Kruger, Jaime A P, Carrilho, Flair J

“…The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed…”
Get full text

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma by Marta, Guilherme Nader, da Fonseca, Leonardo G., Braghiroli, Maria Ignez, Moura, Fernando, Hoff, Paulo M., Sabbaga, Jorge

“…To evaluate the efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC). We analyzed data from a cohort of patients…”
Get full text

Controversies in the management of hepatocellular carcinoma by Forner, Alejandro, Da Fonseca, Leonardo G, Díaz-González, Álvaro, Sanduzzi-Zamparelli, Marco, Reig, María, Bruix, Jordi

“…The management of hepatocellular carcinoma (HCC) has evolved considerably over the last decade. Surveillance of cirrhotic patients and refinements to imaging…”
Get full text

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer by Knebel, Franciele H, Bettoni, Fabiana, da Fonseca, Leonardo G, Camargo, Anamaria A, Sabbaga, Jorge, Jardim, Denis L

“…Anti-EGFR antibodies are a standard care for advanced -wild type colorectal cancers. Circulating tumor DNA (ctDNA) monitoring during therapy can detect…”
Get full text

Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma by da Fonseca, Leonardo G., Reig, Maria, Bruix, Jordi

“…Sorafenib was the first tyrosine kinase inhibitor (TKI) that showed success in extending survival in patients with advanced hepatocellular carcinoma (HCC). In…”
Get full text

Low Baseline Plasma L-Glutamine Concentration Identifies Hepatocellular Carcinoma Patients at High Risk of Developing Early Gastrointestinal Adverse Events during Sorafenib Treatment by Boix, Loreto, Sapena, Víctor, Samper, Esther, Díaz-González, Álvaro, Llarch, Neus, Iserte, Gemma, Da Fonseca, Leonardo G., Sanduzzi-Zamparelli, Marco, Forner, Alejandro, Bruix, Jordi, Reig, María

“…Gastrointestinal adverse events (GIAEs) are common in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. Diarrhea is a prevalent…”
Get full text

Response to Paclitaxel in an Adult Patient with Advanced Kaposiform Hemangioendothelioma by Mota, José Maurício, Scaranti, Mariana, Fonseca, Leonardo G., Tolói, Diego Araújo, de Camargo, Veridiana Pires, Munhoz, Rodrigo Ramella, Feher, Olavo, Hoff, Paulo M.

“…Background: Kaposiform hemangioendothelioma (KHE) is a rare neoplasm of vascular origin that typically arises from the skin or soft tissues as a solitary…”
Get full text

The complexity of cholangiocarcinoma goes beyond clinical practice: Challenges in trials design and interpretation by Da Fonseca, Leonardo G., Forner, Alejandro

Get full text

Increasing alternatives in systemic treatment for hepatocellular carcinoma: Will algorithms be understandable? by Da Fonseca, Leonardo G., Forner, Alejandro

Get full text

Adherence and quality are key for a beneficial HCC surveillance by Da Fonseca, Leonardo G., Forner, Alejandro

Get full text

Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients by Díaz-González, Álvaro, Vilana, Ramón, Bianchi, Luis, García-Criado, Ángeles, Rimola, Jordi, Rodríguez de Lope, Carlos, Ferrer, Joana, Ayuso, Carmen, Da Fonseca, Leonardo G., Reig, María, Forner, Alejandro

“…To assess the effectiveness, safety, and overall survival (OS) of thermal ablation as upfront treatment of intrahepatic colangiocarcinoma (ICC) in patients…”
Get full text

Carbon‐ion radiotherapy for HCC—A potential tool to fulfil an unmet gap in the treatment algorithms? by Da Fonseca, Leonardo G, Forner, Alejandro

“…See Article on Page 2239…”
Get full text

Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients by Barroso-Sousa, Romualdo, Munhoz, Rodrigo R, Mak, Milena P, Fonseca, Leonardo G, Fede, Angelo B S, Linck, Rudinei Diogo Marques, Coelho, Clovis R, Moniz, Camila M V, Souza, Ciro E, Dzik, Carlos

“…To assess the activity, safety and treatment patterns of sunitinib in patients with poor-risk metastatic renal cell carcinoma (mRCC). We retrospectively…”
Get full text

The alpha and ßeta in phase II trials hepatocellular carcinoma ‐ A tale of more than radiological response? by Da Fonseca, Leonardo G, Wörns, Marcus‐A

“…See Article on Page 1468…”
Get full text

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success by Da Fonseca, Leonardo G, Reig, Maria, Bruix, Jordi

Get full text

Review on TAS-102 development and its use for metastatic colorectal cancer by Mota, Jose Mauricio, Fonseca, Leonardo G, Braghiroli, Maria Ignez, Hoff, Paulo M

“…Highlights • Trifluridine, a fluoropyrimidine, had previously had its clinical development halted due to its rapid degradation by thymidine phosphorylase. •…”
Get full text